Hemispherx Biopharma (HEB) Announces Financial Results for the Three Months Ended March 31, 2013
5/9/2013 10:20:20 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
PHILADELPHIA, May 8, 2013 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced its financial results for the three months ended March 31, 2013. The net loss (including non-cash effects) was approximately $3,611,000 or $(0.02) per share as compared to a net loss of $2,308,000 or ($0.02) per share for the same three month period in 2012. This First Quarter-to-Quarter increase in net loss of approximately $1,303,000 was predominantly caused by:
Help employers find you! Check out all the jobs and post your resume.
comments powered by